Show simple item record

dc.contributor.authorSprenger, Kayla G
dc.contributor.authorLouveau, Joy E
dc.contributor.authorMurugan, Pranav M
dc.contributor.authorChakraborty, Arup K
dc.date.accessioned2021-10-27T20:24:05Z
dc.date.available2021-10-27T20:24:05Z
dc.date.issued2020
dc.identifier.urihttps://hdl.handle.net/1721.1/135574
dc.description.abstract© 2020 National Academy of Sciences. All rights reserved. Natural infections and vaccination with a pathogen typically stimulate the production of potent antibodies specific for the pathogen through a Darwinian evolutionary process known as affinity maturation. Such antibodies provide protection against reinfection by the same strain of a pathogen. A highly mutable virus, like HIV or influenza, evades recognition by these strain-specific antibodies via the emergence of new mutant strains. A vaccine that elicits antibodies that can bind to many diverse strains of the virus—known as broadly neutralizing antibodies (bnAbs)—could protect against highly mutable pathogens. Despite much work, the mechanisms by which bnAbs emerge remain uncertain. Using a computational model of affinity maturation, we studied a wide variety of vaccination strategies. Our results suggest that an effective strategy to maximize bnAb evolution is through a sequential immunization protocol, wherein each new immunization optimally increases the pressure on the immune system to target conserved antigenic sites, thus conferring breadth. We describe the mechanisms underlying why sequentially driving the immune system increasingly further from steady state, in an optimal fashion, is effective. The optimal protocol allows many evolving B cells to become bnAbs via diverse evolutionary paths.
dc.language.isoen
dc.publisherProceedings of the National Academy of Sciences
dc.relation.isversionof10.1073/PNAS.1919329117
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
dc.sourcePNAS
dc.titleOptimizing immunization protocols to elicit broadly neutralizing antibodies
dc.typeArticle
dc.contributor.departmentMassachusetts Institute of Technology. Institute for Medical Engineering & Science
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technology
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemical Engineering
dc.contributor.departmentMassachusetts Institute of Technology. Department of Physics
dc.contributor.departmentRagon Institute of MGH, MIT and Harvard
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistry
dc.relation.journalProceedings of the National Academy of Sciences of the United States of America
dc.eprint.versionFinal published version
dc.type.urihttp://purl.org/eprint/type/JournalArticle
eprint.statushttp://purl.org/eprint/status/PeerReviewed
dc.date.updated2021-06-08T17:18:35Z
dspace.orderedauthorsSprenger, KG; Louveau, JE; Murugan, PM; Chakraborty, AK
dspace.date.submission2021-06-08T17:18:36Z
mit.journal.volume117
mit.journal.issue33
mit.licensePUBLISHER_POLICY
mit.metadata.statusAuthority Work and Publication Information Needed


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record